AbbVie (ABBV)
(Delayed Data from NYSE)
$195.40 USD
-0.52 (-0.27%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $195.10 -0.30 (-0.15%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Brokerage Reports
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 321 - 340 ( 385 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended July 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended June 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended June 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 11This report contains brief updates on the following: ANAC, CELG, IRWD, AZN, MDVN, PFE, ABBV, GLD. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 4
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Feb 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D